4 unknown. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 4 |
Follow Auto CAR-T: new trials by email Literature Review of Auto CAR-T trials Research Report on Auto CAR-T
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma Auto CAR-T, Cyclophosphamide,Fludarabine, Leukapheresis - Non-hodgkin's Lymphoma | Not applicable | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 200 | 2020-10-22 | 2020-12-14 |
| Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors Auto CAR-T, Cyclophosphamide,Fludarabine, Leukapheresis - Plasma Cell Tumors | Not applicable | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 60 | 2020-10-22 | 2020-12-11 |
| A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma Auto CAR-T, Cyclophosphamide,Fludarabine, Leukapheresis - Hodgkin's Lymphoma | Not applicable | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 20 | 2020-10-22 | 2020-12-29 |
| Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children Auto CAR-T, Cyclophosphamide,Fludarabine, Leukapheresis - Leukemia, Lymphoma | Not applicable | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 30 | 2020-06-23 | 2020-10-30 |
Hodgkin Disease (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Plasmacytoma (1)
Hebei Senlang Biotechnology Inc., Ltd. (4)
China (4)
Baoen Shan, PhD & MD (3) · Lihong Liu, PhD & MD (3) · Lian Jiang, MD (1)